Emerging Skin Toxicities in Patients with Breast Cancer Treated with New Cyclin-Dependent Kinase 4/6 Inhibitors: A Systematic Review Martina SilvestriAntonio CristaudoNorma Cameli Review Article 06 May 2021 Pages: 725 - 732
Risk Minimization of Antibody–Drug Conjugates in Oncology: A Review Fabio A. LievanoLinda J. ScarazziniCheryl L. Renz Review Article 14 May 2021 Pages: 733 - 742
A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs Ameet SarpatwariMayookha Mitra-MajumdarAaron S. Kesselheim Study Design 27 April 2021 Pages: 743 - 751
Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin Efe EworukeLaura HouTing-Ying Huang Original Research Article 20 May 2021 Pages: 753 - 763
Signal Detection in EUROmediCAT: Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference Alana CavadinoLovisa SandbergJoan K Morris Original Research Article 09 May 2021 Pages: 765 - 785
Risk of Pregnancy Termination and Congenital Anomalies After Domperidone Exposure: A Study in the EFEMERIS Database Mélanie AraujoClémentine VabreIsabelle Lacroix Original Research Article 10 May 2021 Pages: 787 - 796
Comparison of Longitudinal and Cross-Sectional Approaches in Studies About Knowledge, Attitude, and Practices Related to Antibiotic Misuse Narmeen MallahAdolfo FigueirasBahi Takkouche Original Research Article 10 May 2021 Pages: 797 - 809
Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials Marta López-FauquedMaribel Co-van der MeeFernanda Tavares-da-Silva Original Research Article Open access 11 June 2021 Pages: 811 - 823